On air · 1 of 3 networks
AiFChem
- bit.ly
- Healthcare & Life Sciences
- US
- 18 employees
AiFChem’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 76. Watch AiFChem with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 49 | Checked 30 Oct 2026 | See all 76 ads → | ||
| Meta | Not checked | — | |||
| Not checked | — |
AiFChem has 49 live LinkedIn ads.
Latest ads
- LINKEDIN · IMAGESince 24 Jul 2026
📅 Stay tuned for the launch of AiFChem Website 3.0 At AiFChem, we've always been committed to building an intelligent research ecosystem that empowers scientists to innovate with greater intelligence and efficiency. Now, we're taking the next step with a new digital experience—built around a next-generation intelligent research ecosystem, powered by AiFChem Agent. Over the next few days, we'll take you inside Website 3.0 and share what's new before the launch. Stay tuned. 🚀
- LINKEDIN · IMAGESince 23 Jul 2026
Modified Nucleosides and Nucleotides are structurally modified derivatives of canonical nucleic acid building blocks, featuring chemical modifications in their sugar moieties, nucleobases, or phosphate groups. These modified molecules serve as valuable tools in nucleic acid chemistry and molecular biology, enabling the investigation of nucleic acid structure, function, metabolism, and biological regulation. Driven by advances in molecular biology and therapeutic development, modified nucleosides and nucleotides have become important components in research and development across nucleic acid therapeutics, genetic engineering, and molecular diagnostics. AiFChem provides a comprehensive portfolio of Base-Modified Nucleosides, Sugar-Modified Nucleosides, and Modified NTPs & dNTPs to support diverse R&D applications. Explore: https://lnkd.in/gvsNRECT #AiFChem #ModifiedNucleosides #ModifiedNucleotides #NucleicAcidChemistry #RNAModification #OligonucleotideSynthesis #ChemicalBuildingBlocks
- LINKEDIN · IMAGESince 17 Jul 2026
Bicyclo[2.2.2]octane (BCO) is becoming a practical choice for designing compact, 3D saturated scaffolds in lead optimization. As a valuable bioisostere of para-substituted phenyl rings, BCO can help lock molecular conformation, modulate physicochemical properties and enable scaffold hopping. Functionalized BCO cores support medicinal chemistry exploration across oncology, antiviral and cardiorenal research, where 3D scaffold design helps access differentiated chemical space. AiFChem offers a broad selection of carboxylic acid, amino, boronate and halogenated BCO building blocks for drug discovery programs. Explore our catalog here: https://lnkd.in/gEJaHWnA #AiFChem #BCOBuildingBlocks #MedChem #DrugDiscovery #Bioisosteres
- LINKEDIN · IMAGESince 16 Jul 2026
The growing interest in peptide-based modalities, including cyclic peptides, peptide conjugates, and macrocyclic peptide structures, is driving demand for reliable and diverse amino acid building blocks. Fmoc-protected amino acids remain essential for solid-phase peptide synthesis (SPPS), enabling precise peptide assembly through efficient Fmoc deprotection and orthogonal side-chain protection strategies. Beyond standard amino acids, access to diverse non-natural and functionalized building blocks is increasingly important for exploring new peptide architectures and fine-tuning peptide properties. AiFChem provides a comprehensive selection of Fmoc-protected amino acids, including standard, non-natural, and specialty building blocks to support advanced peptide synthesis and molecular design. Explore our full catalog: https://lnkd.in/gywMn5gk #AiFChem #FmocAminoAcids #AminoAcids #PeptideSynthesis #SPPS #PeptideChemistry
- LINKEDIN · IMAGESince 10 Jul 2026
Medicinal chemistry SAR optimization frequently utilizes aliphatic gem-dimethyl tertiary alcohol moieties to fine-tune druggability and ADME properties. The aliphatic gem-dimethyl group provides steric shielding that blocks metabolic hotspots, improving compound stability and oral bioavailability. The tertiary hydroxyl group adds a hydrogen-bond donor/acceptor and a modest polarity boost, helping balance logP without introducing a new stereocenter. This aliphatic structural modification is widely adopted in clinical drug optimization, featured in approved molecules Selpercatinib and Linperlisib, and clinical candidate TP-3654. AiFChem offers a diverse collection of high-purity aliphatic gem-dimethyl tertiary alcohol building blocks to support your lead optimization and SAR expansion. Explore here: https://lnkd.in/g37_ZVgH #AiFChem #MedChem #DrugDiscovery #SAR #BuildingBlocks
- LINKEDIN · IMAGESince 2 Jul 2026
AiFChem just concluded four days at NORM 2026 in Boise, ID.👏 Throughout the event, we had the opportunity to introduce the AiFChem AI Agent to attendees, demonstrating how it streamlines building block search and sourcing for research teams. We also shared updates on our newly established US warehouse, enabling faster, more reliable delivery for customers across the country. 💫 We're grateful for the meaningful conversations with researchers, partners, and fellow exhibitors, and we thank the organizers for hosting an exceptional event. Interested in learning more about our products or solutions? Visit us at https://lnkd.in/g6k9PgyY or reach out to our sales team at [[email protected]]— we'd love to connect. 🥰 #AiFChem #NORM2026 #Chemistry
6 of 76 adsSign up to see every AiFChem ad, filter by format and date, and get alerts on new ones.
See all 76 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.